Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
Pt 1
pubmed:dateCreated
2001-1-26
pubmed:abstractText
Highly purified Aplysia californica ADP-ribosyl cyclase was found to be a multifunctional enzyme. In addition to the known transformation of NAD(+) into cADP-ribose this enzyme is able to catalyse the solvolysis (hydrolysis and methanolysis) of cADP-ribose. This cADP-ribose hydrolase activity, which becomes detectable only at high concentrations of the enzyme, is amplified with analogues such as pyridine adenine dinucleotide, in which the cleavage rate of the pyridinium-ribose bond is much reduced compared with NAD(+). Although the specificity ratio V(max)/K(m) is in favour of NAD(+) by 4 orders of magnitude, this multifunctionality allowed us to propose a 'partitioning' reaction scheme for the Aplysia enzyme, similar to that established previously for mammalian CD38/NAD(+) glycohydrolases. This mechanism involves the formation of a single oxocarbenium-type intermediate that partitions to cADP-ribose and solvolytic products via competing pathways. In favour of this mechanism was the finding that the enzyme also catalysed the hydrolysis of NMN(+), a substrate that cannot undergo cyclization. The major difference between the mammalian and the invertebrate enzymes resides in their relative cyclization/hydrolysis rate-constant ratios, which dictate their respective yields of cADP-ribose (ADP-ribosyl cyclase activity) and ADP-ribose (NAD(+) glycohydrolase activity). For the Aplysia enzyme's catalysed transformation of NAD(+) we favour a mechanism where the formation of cADP-ribose precedes that of ADP-ribose; i.e. macroscopically the invertebrate ADP-ribosyl cyclase conforms to a sequential reaction pathway as a limiting form of the partitioning mechanism.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-10400320, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-10413485, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-10521467, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-10600637, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-1471258, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-1650254, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-1650255, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-1830494, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-203460, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-2466645, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-3496336, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-6279, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-7775378, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-7941427, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-7980606, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-7982936, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-8235624, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-8250903, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-8391778, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-8395705, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-8527487, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-8798630, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-8901875, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-9193683, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-9211328, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-9354813, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-9494110, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-9748331, http://linkedlifedata.com/resource/pubmed/commentcorrection/10861229-9858777
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
349
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
203-10
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Unifying mechanism for Aplysia ADP-ribosyl cyclase and CD38/NAD(+) glycohydrolases.
pubmed:affiliation
Laboratoire de Chimie Bioorganique, UMR 7514 CNRS-ULP, Faculté de Pharmacie, 74 route du Rhin, 67400 Strasbourg-Illkirch, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't